Thrombopoietin emerges as a new haematopoietic cytokine that confers cardioprotection against acute myocardial infarction

被引：3

作者：

Calvert, John W. ^{[2
]}

Lefer, David J. ^{[1
,2
]}

机构：

[1] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA

[2] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Div Cardiol, Bronx, NY 10461 USA

来源：

CARDIOVASCULAR RESEARCH | 2008年 / 77卷 / 01期

关键词：

D O I：

10.1093/cvr/cvm064

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

Editorial commentary on 'Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats'.

引用

页码：2 / 3

页数：2

共 15 条

[1]

Erythropoietin mimics ischemic preconditioning [J].

Baker, JE .

VASCULAR PHARMACOLOGY, 2005, 42 (5-6) :233-241

[2]

Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats [J].

Baker, John E. ;

Su, Jidong ;

Hsu, Anna ;

Shi, Yang ;

Zhao, Ming ;

Strande, Jennifer L. ;

Fu, Xiangping ;

Xu, Hao ;

Eis, Annie ;

Komorowski, Richard ;

Jensens, Eric S. ;

Tweddell, James S. ;

Rafiee, Parvaneh ;

Gross, Garrett J. .

CARDIOVASCULAR RESEARCH, 2008, 77 (01) :44-53

[3]

Role of the JAK-STAT pathway in myocardial injury [J].

Barry, Sean P. ;

Townsend, Paul A. ;

Latchman, David S. ;

Stephanou, Anastasis .

TRENDS IN MOLECULAR MEDICINE, 2007, 13 (02) :82-89

[4]

Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke [J].

Bath, P. M. W. ;

Sprigg, N. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02)

[5]

Statin therapy and myocardial no-reflow [J].

Calvert, J. W. ;

Lefer, D. J. .

BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (03) :229-231

[6]

Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning [J].

Gross, GJ ;

Fryer, RM .

CIRCULATION RESEARCH, 1999, 84 (09) :973-979

[7]

G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes [J].

Harada, M ;

Qin, YJ ;

Takano, H ;

Minamino, T ;

Zou, YZ ;

Toko, H ;

Ohtsuka, M ;

Matsuura, K ;

Sano, M ;

Nishi, J ;

Iwanaga, K ;

Akazawa, H ;

Kunieda, T ;

Zhu, WD ;

Hasegawa, H ;

Kunisada, K ;

Nagai, T ;

Nakaya, H ;

Yamauchi-Takihara, K ;

Komuro, I .

NATURE MEDICINE, 2005, 11 (03) :305-311

[8]

Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury [J].

Hilfiker-Kleiner, D ;

Hilfiker, A ;

Fuchs, M ;

Kaminski, K ;

Schaefer, A ;

Schieffer, B ;

Hillmer, A ;

Schmiedl, A ;

Ding, ZP ;

Podewski, E ;

Poli, V ;

Schneider, MD ;

Schulz, R ;

Park, JK ;

Wollert, KC ;

Drexler, H .

CIRCULATION RESEARCH, 2004, 95 (02) :187-195

[9]

The molecular mechanisms that control thrombopoiesis [J].

Kaushansky, K .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (12) :3339-3347

[10]

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy [J].

Kunisada, K ;

Negoro, S ;

Tone, E ;

Funamoto, M ;

Osugi, T ;

Yamada, S ;

Okabe, M ;

Kishimoto, T ;

Yamauchi-Takihara, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (01) :315-319

← 1 2 →